Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
Palmieri, C, Gojis, O, Rudraraju, B, Stamp-Vincent, C, Wilson, D, Langdon, S, Gourley, C, Faratian, D
Published in British journal of cancer (28.05.2013)
Published in British journal of cancer (28.05.2013)
Get full text
Journal Article
Methylation of the calcium channel regulatory subunit α2δ-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
Palmieri, C, Rudraraju, B, Monteverde, M, Lattanzio, L, Gojis, O, Brizio, R, Garrone, O, Merlano, M, Syed, N, Lo Nigro, C, Crook, T
Published in British journal of cancer (10.07.2012)
Published in British journal of cancer (10.07.2012)
Get full text
Journal Article
Methylation of the calcium channel regulatory subunit alpha 2 delta -3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
Palmieri, C, Rudraraju, B, Monteverde, M, Lattanzio, L, Gojis, O, Brizio, R, Garrone, O, Merlano, M, Syed, N, Lo Nigro, C, Crook, T
Published in British journal of cancer (10.07.2012)
Published in British journal of cancer (10.07.2012)
Get full text
Journal Article
High frequency of complex TP53 mutations in CNS metastases from breast cancer
Lo Nigro, C, Vivenza, D, Monteverde, M, Lattanzio, L, Gojis, O, Garrone, O, Comino, A, Merlano, M, Quinlan, P R, Syed, N, Purdie, C A, Thompson, A, Palmieri, C, Crook, T
Published in British journal of cancer (17.01.2012)
Published in British journal of cancer (17.01.2012)
Get full text
Journal Article
NT5E CpG island methylation is a favourable breast cancer biomarker
Lo Nigro, C, Monteverde, M, Lee, S, Lattanzio, L, Vivenza, D, Comino, A, Syed, N, McHugh, A, Wang, H, Proby, C, Garrone, O, Merlano, M, Hatzimichael, E, Briasoulis, E, Gojis, O, Palmieri, C, Jordan, L, Quinlan, P, Thompson, A, Crook, T
Published in British journal of cancer (26.06.2012)
Published in British journal of cancer (26.06.2012)
Get full text
Journal Article
Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
Palmieri, C, Monteverde, M, Lattanzio, L, Gojis, O, Rudraraju, B, Fortunato, M, Syed, N, Thompson, A, Garrone, O, Merlano, M, Lo Nigro, C, Crook, T
Published in British journal of cancer (07.08.2012)
Published in British journal of cancer (07.08.2012)
Get full text
Journal Article
The role of steroid receptor coactivator-3 (SRC-3) in human malignant disease
Gojis, O, Rudraraju, B, Alifrangis, C, Krell, J, Libalova, P, Palmieri, C
Published in European journal of surgical oncology (01.03.2010)
Published in European journal of surgical oncology (01.03.2010)
Get full text
Journal Article
O-39 HER2 positive early breast cancers: What proportion are receiving adjuvant Trastuzumab therapy? A multicentre audit
Marla, S, Cardale, J, Dodwell, D.J, Skene, A.I, Gojis, O, Abram, P, Palmieri, C, Cleator, S.J, Bowman, A, Doughty, J.C
Published in European journal of cancer supplements (01.09.2010)
Published in European journal of cancer supplements (01.09.2010)
Get full text
Journal Article
94 A multicentre audit of HER2 positive Early Breast Cancers and the reasons why patients do not receive trastuzumab therapy
Marla, S, Cardale, J, Dodwell, D.J, Skene, A.I, Abram, P, Palmieri, C, Cleator, S.J, Gojis, O, Tovey, S.M, Doughty, J.C
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
Reconstruction of maxilla alveolus for application of dental implant in patients with cleft defect
Dusková, M, Kot'ová, M, Urban, F, Sosna, B, Jirkalová, R, Strnadel, T, Kristen, M, Leamerová, E, Gojis, O
Published in Acta chirurgiae plasticae (Anglická verze) (2004)
Get more information
Published in Acta chirurgiae plasticae (Anglická verze) (2004)
Journal Article
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
FRANCIS, Richard E, MYATT, Stephen S, PALMIERI, Carlo, PESTON, David, SHOUSHA, Sami, QUNYAN YU, SICINSKI, Piotr, COOMBES, R. Charles, LAM, Eric W.-F, KROL, Janna, HARTMAN, Johan, PECK, Barrie, MCGOVERN, Ursula B, JUN WANG, GUEST, Stephanie K, FILIPOVIC, Aleksandra, GOJIS, Ondrej
Published in International journal of oncology (01.07.2009)
Published in International journal of oncology (01.07.2009)
Get full text
Journal Article
Abstract P2-10-22: Phosphorylation of Steroid Receptor Coactivator 3 (SRC3) at Ser543 is a novel independent prognostic marker in breast cancer
Palmieri, C, Gojis, O, Rudraraju, B, Abdel-Fatah, TMA, Moore, D, Shaw, J, Green, A, Ellis, IO, Coombes, RC, Ali, S
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Published in Cancer research (Chicago, Ill.) (15.12.2012)
Get full text
Journal Article
Methylation of the calcium channel regulatory subunit [alpha]2[delta]-3 (CACNA2D3) predicts site-specific relapse in oestrogen receptor-positive primary breast carcinomas
Palmieri, C, Rudraraju, B, Monteverde, M, Lattanzio, L, Gojis, O, Brizio, R, Garrone, O, Merlano, M, Syed, N, Lo Nigro, C, Crook, T
Published in British journal of cancer (10.07.2012)
Published in British journal of cancer (10.07.2012)
Get full text
Journal Article
P1-12-11: Neoadjuvant Chemotherapy-Trastuzumab Versus Neoadjuvant Chemotherapy Followed by Post-Operative Trastuzumab: A Multicentre Study
Palmieri, C, Yan, K, Owadally, W, Shah, D, Gojis, O, North, B, Riddle, P, Ahmad, R, Lewanski, C, Coombes, RC, Cleator, S, Howell, S, Beresford, M
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Published in Cancer research (Chicago, Ill.) (15.12.2011)
Get full text
Journal Article
Management and outcome of HER2-positive breast cancer treated with and without adjuvant trastuzumab: The Imperial College London experience
Shah, D., Gojis, O., Krell, J., Ahmad, R., Riddle, P., Coombes, R. C., Leonard, R. C., Fox, K., Cleator, S. J., Palmieri, C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
HER2-positive early breast cancers: What proportion are receiving adjuvant trastuzumab therapy? A multicenter audit
Marla, S., Cardale, J., Dodwell, D. J., Skene, A., Gojis, O., Palmieri, C., Abram, P., Cleator, S., Bowman, A., Doughty, J. C.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article